Stay updated on Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Updated the Chile location text to use “Araucania” / “Temuco, Araucania, Chile” instead of “Región de la Araucanía” variants.
    Difference
    0.1%
    Check dated 2026-04-23T04:48:49.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T02:15:07.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Naples, Italy, 80131 was added as a study location, replacing Napoli, Italy, 80131. The page revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-25T07:09:46.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Added updates to eligibility criteria, including prior PD-1/PD-L1/CTLA-4 exposure and prior MSD pembrolizumab participation. Expanded and clarified endpoint definitions (EFS, pathCR, OS) and adverse events across neoadjuvant/adjuvant cohorts, and updated study identifiers and revision metadata (EudraCT number, v3.4.3) with dates.
    Difference
    0.4%
    Check dated 2026-03-10T17:33:18.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Gastric cancer is now listed as the study focus. The Resources section now includes the Genetic and Rare Diseases Information Center, and the page revision has been updated to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-17T03:08:54.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-09T22:52:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Gastric Cancer Clinical Trial page.